$Actinium (ATNM.US)$NorthStar Medical Radioisotopes and YAP Therapeutics Enter Into Collaboration Agreement for the Development and Production of Radiopharmaceutical Products Businesswire· 13 mins ago NorthStar to support the development of YAP Therapeutics' innovative radiolabeled productsThis collaboration merges the expertise and resources from both companies, including NorthStar's state-of-the-art facilitiesThe agreement guarantees that YAP Therapeutics will receive clinical trial-read...
$Actinium (ATNM.US)$SK Biopharmaceuticals Seals 1st Actinium-225-Based Collaborative Research Agreement With Korea Institute of Radiological and Medical Sciences as Steps Toward Becoming Global Radiopharmaceutical Therapy Player PR Newswire· 10 mins ago SK Biopharmaceuticals, Korea Institute of Radiological and Medical Sciences collaborate on discovering and developing radiopharmaceutical drug candidates using an alpha-particleemittingradioisotope, actinium-225, for potential cancer treatm...
$Actinium (ATNM.US)$Not sure why this didn't pop up on the Moomoo news fees but it's back to another Phase 3 for their AML drug. Actinium Announces Publication Of Phase 3 SIERRA Results Of Iomab-B - Quick Facts Good lesson on the higher risks of biologics though. BLA (biologics license application) a relatively new classification (maybe 5 or so years?) meant to divert biologics from the NDA process that small molecule drugs go through. In practical terms,...
$Actinium (ATNM.US)$Abdera Therapeutics Announces FDA Orphan Drug Designation for ABD-147 for the Treatment of Neuroendocrine Carcinoma September 05, 2024 08:00 AM Eastern Daylight Time!!! From this morning! BUT THIS ONE BELOW JUST WAS RELEASED VIA SEEKING ALPHA! NOT SURE IF THEY ARE MISPRINT OF DRUG? OR ANOTHER APPROVAL? Perspective gets FDA fast track status for radiopharmaceutical VMT101
Following the introduction of China's groundbreaking DeepSeek technology, Wall Street giants have revised their investment outlooks for the Chinese market.
Actinium Stock Forum
Businesswire· 13 mins ago
NorthStar to support the development of YAP Therapeutics' innovative radiolabeled productsThis collaboration merges the expertise and resources from both companies, including NorthStar's state-of-the-art facilitiesThe agreement guarantees that YAP Therapeutics will receive clinical trial-read...
PR Newswire· 10 mins ago
SK Biopharmaceuticals, Korea Institute of Radiological and Medical Sciences collaborate on discovering and developing radiopharmaceutical drug candidates using an alpha-particleemittingradioisotope, actinium-225, for potential cancer treatm...
Actinium Announces Publication Of Phase 3 SIERRA Results Of Iomab-B - Quick Facts
Good lesson on the higher risks of biologics though. BLA (biologics license application) a relatively new classification (maybe 5 or so years?) meant to divert biologics from the NDA process that small molecule drugs go through.
In practical terms,...
Actinium Pharmaceuticals Inc - Iomab-B Well Tolerated in Older Relapsed/Refractory Aml Patients
September 05, 2024 08:00 AM Eastern Daylight Time!!! From this morning! BUT THIS ONE BELOW JUST WAS RELEASED VIA SEEKING ALPHA! NOT SURE IF THEY ARE MISPRINT OF DRUG? OR ANOTHER APPROVAL?
Perspective gets FDA fast track status for radiopharmaceutical VMT101
No comment yet